| GANAXOLONE | None | ||
| 50MG/1ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ZTALMY is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older. | |||
|
Yes
| |||
| ZTALMY | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ***** ********** ************ *** ******* *** *** ****** *** *** ******* | ****** ********** ************ *** ******* *** *** ****** *** *** ******* | ****** ********** ************ *** ******* *** *** ****** *** *** ******* | ***** ********** ************ *** ******* *** *** ****** *** *** ******* | ***** ********** ************ *** ******* *** *** ****** *** *** ******* | ***** ********** ************ *** ******* *** *** ****** *** *** ******* | ****** ********** ************ *** ******* *** *** ****** *** *** ******* | ******* *** ************ *** ********* ** ********* ********* | ********** *** *** ** ******** ******** ********* ******* *** ******* ********* | ******* *** ************ *** ********* ** ********* ********* | ********** *** *** ** ******** ******** ********* ******* *** ******* ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|